SBIR/STTR Research Award
Optimization of Pre- and Post-Operative Pain Management
Award amount
$224,949Program and phase
STTR · Phase IAward year
2016Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- CHANGE MANAGEMENT CONSULTING, LLC
- Proposal award date
- 2016-09-15
- Contract end date
- 2018-08-31
- UEI
- Not reported
- Solicitation number
- PA15-270
- Topic code
- NIDA
Research abstract
Abstract
Despite joint replacement surgeries becoming an increasingly common surgical procedure uncontrolled post
operative pain is a major cause of patient suffering and dissatisfaction and leads to chronic pain Development
of chronic post surgical pain often treated with opioids is frequent and recognized as a major clinical problem
Persistent opioid use due to uncontrolled chronic pain is associated with increased morbidity mortality
disability and social costs Notably patients on long acting opioids are more likely to incur higher healthcare
costs and utilization during the month period following surgery compared with patients who did not receive
long acting opioids Despite the relatively large number of patients being treated with opioids for postoperative
pain there is a dearth of resources to help patients cope and manage their pain The goal of this proposal is to
develop an intervention to improve safety and outcomes of pain management for individuals undergoing joint
replacement surgery by facilitating timely and appropriate use of pain self management The objective of this
Phase proposal is to develop a mobile app based patient education and training intervention designed
specifically to improve patient understanding of pain and self management during the post operative recovery
for individuals undergoing joint arthroplasty We will accomplish this by conducting focus groups to
describe the key pain management and opioid concerns of pre and post surgical patients for hip or knee
arthroplasty use focus group findings to inform development of a mobile app based education module
to provide support for pain and self management principles during the duration of the perioperative
process and perform usability testing of the Perioperative Pain Management Education mobile app
and its integration into the care of patients prior to and following joint arthroplasty The proposed project is
innovative because it uses a new approach to improve pain management that incorporates the use of low cost
commercially available technology to deliver an educational self management intervention to patients Project Narrative
Given the significance of the problems and challenges in the joint arthroplasty patient
population and the imperative to improve safety and outcomes of pain management the
current study aims to facilitate timely access to training and resources on the appropriate use of
pain self management The Perioperative Pain Management Education mobile app is designed
to facilitate timely access to training and resources on the appropriate use of pain self
management This product has high potential impact to prevent persistent pain long term opioid
escalation and disability related to hip and knee surgery
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Wearable Wireless Respiratory Monitoring System that Detects and Predicts Opioid Induced Respiratory Depression
- Building and testing the Life Enhancement and Advocacy Programming digital training tool (LEAPLink) to better serve people with lived experience of homelessness and substance use disorder
- A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder
- Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting.
- Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)